Health Trials

ICI-refractory

1

Review clinical trials related to ICI-refractory. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer

To learn if SAR445877 can help to control locally advanced or metastatic NSCLC in patients who have previously received ICI therapy.

Participants needed: 29
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Aug 20, 2026Locations: 1
Eligibility criteria

Ability to understand and willingness to sign informed consent form (ICF) prior... [+17]

History of allergic reactions attributed to compounds of similar chemical or bio... [+17]

Read more